Trial intelligence / Profile preview

Baxter Advate prophylaxis vs on-demand in Chinese hemophilia A

CTR20140434Phase 4Completed

Sponsor
Baxter International Inc.
Start
Jul 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Baxter International Inc.. Started Jul 2014; status: completed.

02

Drugs

recombinant human coagulation factor VIII
03

Conditions

hemophilia A

Beyond the preview

Go deeper on CTR20140434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call